Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Gene Editing Market?

In recent years, there has been a rapid expansion in the size of the gene editing market. The market, which was worth $8.82 billion in 2024, is expected to increase to $10.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.0%. Factors contributing to this growth during the historic period include the discovery of crispr-cas9, improvements in genetic sequencing, medical advances, funding for scientific research, and the expansion of the biotech industry.

The predicted rapid expansion in the gene editing market size will result in it reaching $20.62 billion in 2029, with an 18.9% compound annual growth rate (CAGR). The projected growth during the forecast period is due to the broadening of therapeutic applications, improvements in precision and efficiency, commercialization of gene therapy, the development of agricultural applications, and the growth in regenerative medicine. Factors that are set to trend during this period include multiplex editing techniques, innovations in base editing, gene drives and population modification, non-viral delivery systems, as well as disease modeling and drug discovery.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What Growth-Enabling Forces Are Impacting The Gene Editing Market?

The surge in the gene editing market is attributed to the rising incidence of transmissible diseases, thus necessitating the use of gene editing methods for their discovery and therapy. Transmissible diseases are conditions spread by infectious microorganisms such as bacteria, viruses, or parasites, which can be passed between individuals, animals, or the environment. The use of gene editing tools is escalating to create specific strategies that can detect and tackle these pathogens at their genetic source, thereby improving disease control and prevention methods. For instance, the World Economic Forum, a Switzerland-based international NGO, noted in 2023 that viral infections such as influenza and respiratory syncytial virus (RSV) have been on the rise since the pandemic. As of February 2023, it was estimated that in the USA alone, influenza caused 24 million cases, resulted in 260,000 hospitalizations, and led to 16,000 deaths. Furthermore, the World Health Organization reported in 2022 that tuberculosis infected 10.6 million people worldwide, with 1.3 million fatalities related to the disease. Thus, transmissible diseases are significantly bolstering the gene editing market.

How Does The Gene Editing Market Differ By Segment?

The gene editingmarket covered in this report is segmented –

1) By Technology: CRISPR; TALEN; ZFN

2) By Application: Animal Genetic Engineering; Plant Genetic Engineering; Cell Line Engineering

3) By End Users: Biotechnology; Pharmaceutical; Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9; CRISPR-Cas12; CRISPR-Cas13; CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs; Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs; Commercial ZFN Kits

What Are The Dominant Trends Currently Seen In The Gene Editing Market?

Leading companies in the gene editing market are pioneering new methods in the sector, such as a methodology based on unique cell-penetrating peptides, in a bid to stay ahead of their competitors. This potentially game-changing technique could drastically accelerate the creation of advanced therapeutic solutions for cancer and various other diseases. Penn Medicine, a prominent multi-hospital healthcare private network from the USA, discovered in April 2023 that protein fragments that some viruses utilize for cell penetration can be used to transport CRISPR-Cas gene editing molecules into cells’ DNA-containing nuclei, resulting in exceptionally high efficiency with minimal cellular toxicity. The researchers believe this novel method will be exceptionally advantageous for modifying T cells and related cells from a patient’s body for creating cell therapies. One such potential application is CAR T (chimeric antigen receptor T cell) therapy, a method employing specially modified patient-derived immune cells for cancer treatment. This novel technique of cellular genetic engineering forecasts notable enhancements in speed and efficiency, and a significant decrease in cellular toxicity when compared to current techniques.

Who Are The Most Influential Companies In The Gene Editing Market?

Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Which Region Is Leading Innovation In The Gene Editing Market?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

Browse Through More Reports Similar to the Global Gene Editing Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Consumables And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-culture-consumables-and-equipment-global-market-report

Biologics Market 2025

https://www.thebusinessresearchcompany.com/report/biologics-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model